Dave S.�B. Hoon
0000-0003-1915-3683
Publication & Citation Trends
Publications
763 total
A heterodimer of α and β hemoglobin chains functions as an innate anticancer agent OA
Cited by 1
Semantic Scholar
Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion OA
Cited by 4
Semantic Scholar
Abstract 6375: Transcriptomic signatures in melanoma lymph node metastasis that relate to immune oncology treatment
Cited by 0
Semantic Scholar
Multi-omic characterization of RCC1 expression and its association with molecular alterations, immune phenotypes, and cancer outcomes.
Cited by 2
Semantic Scholar
Abstract CT275: Phase 1 clinical update of allogeneic invariant natural killer T cells (iNKTs), agenT-797, alone or in combination with pembrolizumab or nivolumab in patients with advanced solid tumors
Cited by 5
Semantic Scholar
The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway OA
Cited by 12
Semantic Scholar
Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression OA
Cited by 8
Semantic Scholar
Evidence-based procedures to improve the reliability of circulating miRNA biomarker assays
Cited by 9
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(177)
Cancer Immunotherapy and Biomarkers
(161)
Cancer Genomics and Diagnostics
(158)
Epigenetics and DNA Methylation
(93)
Cutaneous Melanoma Detection and Management
(76)
Affiliations
University of Southern California
Australian National University
Cedars-Sinai Medical Center
The University of Sydney
St. John's Hospital